Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Giuseppe Bargero"'
Autor:
Olivia Segre, Massimo Perotto, Paolo Fornengo, Paolo Cavallo Perin, Chiara Zucco, Giuseppe Bargero, Giulia Novelli, F. Panero, Graziella Bruno, Piercarlo Deambrogio
Publikováno v:
Diabetes
OBJECTIVE To determine to what extent plasma C-reactive protein (CRP) values influence 5-year all-cause and cardiovascular mortality in type 2 diabetic individuals, independently of albumin excretion rate (AER) and other cardiovascular risk factors,
Autor:
Angela Ianni, Gianfranco Pagano, Ilaria Masi, Graziella Bruno, Giuseppe Bargero, Deborah Melis, Paolo Cavallo-Perin, Franco Merletti, Giulia Novelli
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 18:39-45
Background and aims In this study we assessed the prevalence of diagnosed type 2 diabetes and the quality of care during the period 1988–2000 in an Italian population. Methods and results Two population-based surveys, using similar methods and cent
Autor:
Giulia Novelli, Franco Merletti, Massimo Perotto, Gianfranco Pagano, A Soddu, Paolo Cavallo-Perin, Graziella Bruno, Giuseppe Bargero, Deborah Melis
Publikováno v:
Diabetologia. 50:941-948
Estimated glomerular filtration rate (eGFR) predicts mortality in non-diabetic populations, but its role in people with type 2 diabetes is unknown. We assessed to what extent a reduction in eGFR in people with type 2 diabetes predicts 11-year all-cau
Autor:
Graziella Bruno, Giuseppe Bargero, Gianfranco Pagano, Paolo Cavallo-Perin, Stefania Ferrero, Franco Merletti, Annibale Biggeri
Publikováno v:
Diabetologia. 48:427-434
Fibrinogen and elevated AER increase cardiovascular mortality, but few data are available in the type 2 diabetic population. We have conducted an 11-year follow-up study of the Casale Monferrato cohort to assess: (1) the long-term predictive role of
Autor:
Paolo Cavallo-Perin, Giuseppe Bargero, Annibale Biggeri, Franco Merletti, Gianfranco Pagano, Cristina Runzo, Stefano Prina Cerai, Graziella Bruno, Stefania Ferrero
Publikováno v:
Diabetes Care. 27:2689-2694
OBJECTIVE—The aim of this study was to assess in an 11-year survival follow-up of a population-based cohort of type 2 diabetes the predictive role of World Health Organization–defined metabolic syndrome, independent of conventional cardiovascular
Autor:
Stefania Ferrero, Graziella Bruno, Franco Merletti, Giuseppe Bargero, Gianfranco Pagano, Paolo Cavallo Perin, Annibale Biggeri
Publikováno v:
Diabetes Care. 26:2353-2358
OBJECTIVE—Data on the incidence of end-stage renal disease (ESRD) and chronic renal failure from population-based studies in Caucasian type 2 diabetic patients are lacking. To provide such data, a population-based cohort of type 2 diabetic patients
Autor:
Giuseppe Bargero, Stefania Ferrero, Gianfranco Pagano, Paolo Cavallo Perin, Annibale Biggeri, Graziella Bruno, Franco Merletti
Publikováno v:
Diabetes Care. 26:2150-2155
OBJECTIVE—The first sign of diabetic nephropathy is microalbuminuria, but its predictive role of progression to overt nephropathy in type 2 diabetes has not yet been clarified. The aims of this study were to assess during 7 years of follow-up the i
Autor:
Nicola D'Errico, Paolo Cavallo-Perin, Gianfranco Pagano, M Veglio, Graziella Bruno, Giuseppe Bargero, G. Macchia, M. Borra
Publikováno v:
Journal of Clinical Epidemiology. 52:413-417
The aims of this study were to compare the cardiovascular risk profiles of patients with type 2 diabetes mellitus cared for by general practitioners and those regularly attending a diabetes center. Out of an Italian population-based cohort of 1967 di
Publikováno v:
Diabetologia. 35:851-856
The aims of this survey were (1) to estimate the prevalence of known diabetes mellitus in 1988 in Casale Monferrato (Northern Italy); (2) to validate different data sources available in Italy; (3) to identify a population-based cohort of diabetic pat
Autor:
Olivia Segre, Massimo Perotto, F. Panero, Graziella Bruno, Giuseppe Bargero, Paolo Fornengo, Giulia Novelli, Paolo Cavallo-Perin, Chiara Zucco
Publikováno v:
Journal of hypertension. 27(12)
OBJECTIVE: Data on the clinical usefulness of the metabolic syndrome with respect to cardiovascular risk are not conclusive. We have assessed this issue in a large population-based cohort of diabetic and nondiabetic people in Southern Europe. METHODS